Recombinant human thrombopoietin mimetic peptide-Fc fusion protein (Beijing Tide Pharmaceutical)
重组人促血小板生成素模拟肽-Fc融合蛋白（北京泰德制药）
Report date: 2023/04/20 09:43:45
Base Information
Drug NameRecombinant human thrombopoietin mimetic peptide-Fc fusion protein (Beijing Tide Pharmaceutical)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesBeijing Tide Pharmaceutical Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesBeijing Tide Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A